Table 1.
Comparison of PD patient survival
Country | Reference | Number of cases | Mean age, years | DM rate | Time of review | Patient survival |
---|---|---|---|---|---|---|
Hong Kong | Ho et al. [22] | 3,573 | 59.2 | 46% | 1995–2009 | 1 year: 91.1% |
3 years: 69.6% | ||||||
5 years: 50.7% | ||||||
10 years: 26.7% | ||||||
Australia | McDonald and Hurst [23] | 1,660 | n.a. | 33% | 2006–2008 | 1 year: 94% |
3 years: 73% | ||||||
5 years: 54% | ||||||
New Zealand | McDonald and Hurst [23] | 412 | n.a. | 43% | 2006–2008 | 1 year: 94% |
3 years: 77% | ||||||
5 years: 50% | ||||||
Korea | Jin et al. [54] | 7,423 | 58 | 45.20% | 2001–2010 | 1 year: 93.9% |
3 years: 75.2% | ||||||
5 years: 56.9% | ||||||
10 years: 32.3% | ||||||
Singapore | Choo et al. [24] | 1,015 | 58 | 58% | 2000–2008 | 1 year: 88.7% |
5 years: 39.8% | ||||||
10 years: 15.4% | ||||||
Taiwan | Wu et al. [25] | 8,430 | 55.7 | 31.40% | 2000–2009 | 1 year: 95% |
5 years: 60% | ||||||
Thailand | Dhanakijcharoen et al. [20] | 12,753 | n.a. | n.a. | 2008–2011 | 1 year: 79% |
2 years: 66% | ||||||
3 years: 57% |
n.a. = Not assessed.